Patents by Inventor Benjamin Atwell

Benjamin Atwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12780883
    Abstract: Compositions and methods for treating breast cancer. The disclosed peptides bind to EGFR and enhance the trafficking of EGFR to lysosomes for destruction. These peptides and small molecule analogs thereof can be used for treating cancer by reducing EGFR levels and/or by activating immune cells.
    Type: Grant
    Filed: August 10, 2023
    Date of Patent: November 3, 2026
    Assignee: Arizona Board of Regents on Behalf of The University of Arizona
    Inventors: Joyce A. Schroeder, Benjamin Atwell, Angelica Escoto
  • Publication number: 20240166702
    Abstract: Compositions and methods for treating breast cancer. The disclosed peptides bind to EGFR and enhance the trafficking of EGFR to lysosomes for destruction. These peptides and small molecule analogs thereof can be used for treating cancer by reducing EGFR levels and/or by activating immune cells.
    Type: Application
    Filed: August 10, 2023
    Publication date: May 23, 2024
    Inventors: Joyce A. Schroeder, Benjamin Atwell, Angelica Escoto